Ypsomed Holding AG (LON: 0QLQ)

Market Cap	4.44B
Revenue (ttm)	545.04M
Net Income (ttm)	65.70M
Shares Out	n/a
EPS (ttm)	4.81
PE Ratio	67.56
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jul 1, 2024

Volume	3
Average Volume	952
Open	362.00
Previous Close	366.00
Day's Range	362.00 - 362.00
52-Week Range	179.00 - 375.50
Beta	0.97
RSI	58.51
Earnings Date	Feb 12, 2025

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 2,296
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QLQ

Financial Performance

In 2023, Ypsomed Holding AG's revenue was 548.46 million, an increase of 10.25% compared to the previous year's 497.46 million. Earnings were 78.37 million, an increase of 52.83%.

Financial numbers in CHF